WNT3A and osteogenesis imperfecta: Furthermore, the expression of osteogenic genes in BMSCs extracted from OI patients and exposed to Wnt3a recombinant protein exhibited a marked increase in comparison to untreated BMSCs and those treated with DKK1 recombinant protein.